Youcare Pharmaceutical Group Co., Ltd. (688658.SS)
CNY 16.15
(19.99%)
CNY 16.15
(19.99%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 231.75 Million CNY | -34.53% |
| 2022 | 357.94 Million CNY | -43.79% |
| 2021 | 636.82 Million CNY | 29.4% |
| 2020 | 492.15 Million CNY | 50.02% |
| 2019 | 328.05 Million CNY | 1.44% |
| 2018 | 323.41 Million CNY | 71.16% |
| 2017 | 188.94 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 102.67 Million CNY | 71.6% |
| 2024 Q2 | 59.83 Million CNY | -25.54% |
| 2024 Q1 | 80.36 Million CNY | 29.9% |
| 2023 FY | 234.33 Million CNY | -34.53% |
| 2023 Q4 | 61.86 Million CNY | 199.18% |
| 2023 Q1 | 96.3 Million CNY | 526.18% |
| 2023 Q2 | 138.53 Million CNY | 43.85% |
| 2023 Q3 | -62.38 Million CNY | -145.03% |
| 2022 Q3 | 230.27 Million CNY | 167.89% |
| 2022 Q4 | -22.59 Million CNY | -109.81% |
| 2022 Q2 | 85.96 Million CNY | 33.68% |
| 2022 Q1 | 64.3 Million CNY | -68.89% |
| 2022 FY | 357.94 Million CNY | -43.79% |
| 2021 Q4 | 206.7 Million CNY | 9.91% |
| 2021 Q3 | 188.05 Million CNY | 14.7% |
| 2021 Q2 | 163.96 Million CNY | 109.94% |
| 2021 Q1 | 78.09 Million CNY | -62.27% |
| 2021 FY | 636.82 Million CNY | 29.4% |
| 2020 FY | 492.15 Million CNY | 50.02% |
| 2020 Q1 | 40.62 Million CNY | -63.8% |
| 2020 Q4 | 207 Million CNY | 48.65% |
| 2020 Q3 | 139.25 Million CNY | 32.3% |
| 2020 Q2 | 105.26 Million CNY | 159.11% |
| 2019 FY | 328.05 Million CNY | 1.44% |
| 2019 Q4 | 112.2 Million CNY | 105.97% |
| 2019 Q3 | -1.87 Billion CNY | 0.0% |
| 2018 FY | 323.41 Million CNY | 71.16% |
| 2017 FY | 188.94 Million CNY | 0.0% |